106 related articles for article (PubMed ID: 17289802)
21. The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia.
Thörn I; Olsson-Strömberg U; Ohlsen C; Jonsson AM; Klangby U; Simonsson B; Barbany G
Haematologica; 2005 Nov; 90(11):1471-6. PubMed ID: 16266893
[TBL] [Abstract][Full Text] [Related]
22. [Significance of monitoring WT1 mRNA levels of peripheral blood and bone marrow in acute myeloid leukemia].
Kitamura K; Nakano Y; Watamoto K; Koga D; Naoe T
Rinsho Ketsueki; 2010 Dec; 51(12):1748-55. PubMed ID: 21258184
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients.
Farmen RK; Nordgård O; Gilje B; Shammas FV; Kvaløy JT; Oltedal S; Heikkilä R
Breast Cancer Res Treat; 2008 Mar; 108(2):251-8. PubMed ID: 17492378
[TBL] [Abstract][Full Text] [Related]
24. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
[TBL] [Abstract][Full Text] [Related]
25. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia.
Nakao M; Yokota S; Horiike S; Taniwaki M; Kashima K; Sonoda Y; Koizumi S; Takaue Y; Matsushita T; Fujimoto T; Misawa S
Leukemia; 1996 Sep; 10(9):1463-70. PubMed ID: 8751464
[TBL] [Abstract][Full Text] [Related]
26. A reliable method for total RNA extraction from frozen human bone marrow samples taken at diagnosis of acute leukaemia.
Barbaric D; Dalla-Pozza L; Byrne JA
J Clin Pathol; 2002 Nov; 55(11):865-7. PubMed ID: 12401828
[TBL] [Abstract][Full Text] [Related]
27. Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial.
Willekens C; Blanchet O; Renneville A; Cornillet-Lefebvre P; Pautas C; Guieze R; Ifrah N; Dombret H; Jourdan E; Preudhomme C; Boissel N;
Haematologica; 2016 Mar; 101(3):328-35. PubMed ID: 26635039
[TBL] [Abstract][Full Text] [Related]
28. Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow.
Hoon DS; Kuo CT; Wen S; Wang H; Metelitsa L; Reynolds CP; Seeger RC
Am J Pathol; 2001 Aug; 159(2):493-500. PubMed ID: 11485908
[TBL] [Abstract][Full Text] [Related]
29. Non-formalin fixative versus formalin-fixed tissue: a comparison of histology and RNA quality.
Groelz D; Sobin L; Branton P; Compton C; Wyrich R; Rainen L
Exp Mol Pathol; 2013 Feb; 94(1):188-94. PubMed ID: 22814231
[TBL] [Abstract][Full Text] [Related]
30. Sequential detection of tumor cells in the peripheral blood and bone marrow of patients with stage IV neuroblastoma by the reverse transcription-polymerase chain reaction for tyrosine hydroxylase mRNA.
Miyajima Y; Horibe K; Fukuda M; Matsumoto K; Numata S; Mori H; Kato K
Cancer; 1996 Mar; 77(6):1214-9. PubMed ID: 8635146
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of AML1-a and acquired chromosomal abnormalities in childhood acute lymphoblastic leukemia.
Gutiérrez-Angulo M; González-García JR; Meza-Espinoza JP; Picos-Cárdenas VJ; Esparza-Flores MA; López-Guido B; Rivera H
Hematol Oncol; 2004 Sep; 22(3):85-90. PubMed ID: 15991223
[TBL] [Abstract][Full Text] [Related]
32. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.
van der Velden VH; Jacobs DC; Wijkhuijs AJ; Comans-Bitter WM; Willemse MJ; Hählen K; Kamps WA; van Wering ER; van Dongen JJ
Leukemia; 2002 Aug; 16(8):1432-6. PubMed ID: 12145681
[TBL] [Abstract][Full Text] [Related]
33. Gene expression differences between PAXgene and Tempus blood RNA tubes are highly reproducible between independent samples and biobanks.
Skogholt AH; Ryeng E; Erlandsen SE; Skorpen F; Schønberg SA; Sætrom P
BMC Res Notes; 2017 Mar; 10(1):136. PubMed ID: 28335817
[TBL] [Abstract][Full Text] [Related]
34. Standardization of preanalytical factors for minimal residual disease analysis in chronic myelogenous leukemia.
Müller MC; Hördt T; Paschka P; Merx K; La Rosée P; Hehlmann R; Hochhaus A
Acta Haematol; 2004; 112(1-2):30-3. PubMed ID: 15179002
[TBL] [Abstract][Full Text] [Related]
35. Identification of gene expression profiles that segregate patients with childhood leukemia.
Moos PJ; Raetz EA; Carlson MA; Szabo A; Smith FE; Willman C; Wei Q; Hunger SP; Carroll WL
Clin Cancer Res; 2002 Oct; 8(10):3118-30. PubMed ID: 12374679
[TBL] [Abstract][Full Text] [Related]
36. Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1.
Fujiwara T; Sasaki K; Saito K; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Harigae H
Biochem Biophys Res Commun; 2017 Apr; 485(2):380-387. PubMed ID: 28216155
[TBL] [Abstract][Full Text] [Related]
37. Effect of ribonucleic acid (RNA) isolation methods on putative reference genes messenger RNA abundance in human spermatozoa.
Barragán M; Martínez A; Llonch S; Pujol A; Vernaeve V; Vassena R
Andrology; 2015 Jul; 3(4):797-804. PubMed ID: 26097086
[TBL] [Abstract][Full Text] [Related]
38. Recovery of microarray-quality RNA from frozen EDTA blood samples.
Beekman JM; Reischl J; Henderson D; Bauer D; Ternes R; Peña C; Lathia C; Heubach JF
J Pharmacol Toxicol Methods; 2009; 59(1):44-9. PubMed ID: 19028589
[TBL] [Abstract][Full Text] [Related]
39. Detection of neuroblastoma cells in bone marrow and peripheral blood by different techniques: accuracy and relationship with clinical features of patients.
Corrias MV; Faulkner LB; Pistorio A; Rosanda C; Callea F; Piccolo MS; Scaruffi P; Marchi C; Lacitignola L; Occhino M; Gambini C; Tonini GP; Haupt R; De Bernardi B; Pistoia V; Garaventa A
Clin Cancer Res; 2004 Dec; 10(23):7978-85. PubMed ID: 15585633
[TBL] [Abstract][Full Text] [Related]
40. Stabilization of circulating thyroglobulin mRNA transcripts in patients treated for differentiated thyroid carcinoma.
Feddersen S; Bastholt L; Pedersen SM
Ann Clin Biochem; 2017 Sep; 54(5):558-566. PubMed ID: 27629910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
